Accor SA is publicly listed on the Euronext Paris Stock Exchange (ISIN code: FR0000120404) and on the OTC Market (Ticker: ACRFY) in the United States. For more information or to make a reservation, please visit accorhotels.group or …
4-Traders · 16d
One stock that fits that bill is Acorda Therapeutics (ACOR), which saw a welcome improvement to its Relative Strength (RS) Rating on Monday, …
Acorda Therapeutics, Inc. ACOR reported adjusted earnings of 14 cents per share ... Shares of Acorda slipped more than 1% following its earnings release. However, the stock has surged 45% in a year’s time versus the industry’s 13.5% decline.
Finance Yahoo · 1mon
Its lead drug candidate, CVT-301, shows strong potential. The company stock is priced attractively after a sudden slump in its value. Acorda Therapeutics Inc. (NASDAQ:ACOR) stock shows a strong recovery from its April slump, which erased nearly half of its ...
Seeking Alpha · 10mon
UBS kept a "buy" rating on Accor shares, while Bernstein has an "underperform" rating on the stock. Previous acquisitions under Bazin, who took over in 2013, include Toronto-based Fairmont Raffles Hotels International, owner of London's Savoy Hotel ...
4-Traders · 1mon
Recently, the stock has been gaining momentum on takeover speculation. Acorda has upside from current levels based just on Inbrija’s potential. Last Friday, Acorda Therapeutics (ACOR) surged nearly 9% amid reports that the company was seeing takeover ...
Seeking Alpha · 5mon